BC Decker will be moving premises on Friday July 30th, 2010. There will be some interruption to service as we move our servers and phones. We apologize for any inconvenience this may cause and plan to work as quickly as possible to have our services back up and running as soon as possible. Thank-you.
    FEEDBACK     HELP
WELCOME: Not Logged In HOME | MY ACCOUNT | ABOUT US | CONTACT US
SEARCH
ADVANCED
 SHOP OUR CATALOG
 JOURNALS
 BCDECKER WEB SITES >
 REGISTRATION
 FREE EMAIL TOC
 AUTHOR INFORMATION >
 FAQS
 CONFERENCES
 PERMISSION GUIDELINES
 SHIPPING INFORMATION
 PRIVACY POLICY
 ADVERTISERS INFORMATION >
 PHARMA SALES >
 DISTRIBUTION PARTNERS
 
 
LOGIN
USERNAME:
PASSWORD:

SAVE PASSWORD
Forgot My password?
Register
 
External Access > PubMed LinkOut
ISSN Number: 1916-0216
Title: Journal of Otolaryngology-Head And Neck Surgery
Volume Number: 32
Issue Number: 06
Page Number: 351
Published: 6 time(s) per Year

Systematic Review of Intratympanic Gentamicin in Meniere's Disease

AbstractObjectivesTo assess and summarize the best available evidence for the use of intratympanic gentamicin in patients with Meniere's disease with respect to improvement of vertigo, tinnitus, and change in hearing.MethodsComprehensive electronic searches were conducted on the databases of MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials. All generated titles were reviewed, and potentially relevant articles were assessed for inclusion. Data from included articles were extracted and summarized.ResultsOverall pooled results on vertigo control revealed complete or substantial control in 89% of patients (study range 73–100%). Hearing was worsened in 26% (0–90%). Subjective improvement in tinnitus was seen in 57% of patients (0–82%). Different treatment protocols all resulted in similar rates of vertigo control.ConclusionsIntratympanic gentamicin appears effective in controlling the symptoms of Meniere's disease, regardless of the protocol used. Although the literature on this treatment is extensive, there is a likelihood of significant bias in many currently published reports. There is a clear need for a prospective, randomized, blinded, placebo-controlled trial to assess the true effectiveness of this treatment.
Already A Subscriber?

PubMed Publication LinkOut Login
Username:   
Password:   

Non-Subscriber?

If you are not a current online subscriber to Journal of Otolaryngology-Head And Neck Surgery then please click on the link below to purchase the article:

Buy Now!